Inhibikase Therapeutics, Inc. (IKT)
IKT Stock Price Chart
Explore Inhibikase Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze IKT price movements and trends.
IKT Company Profile
Discover essential business fundamentals and corporate details for Inhibikase Therapeutics, Inc. (IKT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Dec 2020
Employees
15.00
Website
https://www.inhibikase.comCEO
Mark T. Iwicki
Description
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
IKT Financial Timeline
Browse a chronological timeline of Inhibikase Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%.
Earnings released on 14 May 2025
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%.
Earnings released on 26 Mar 2025
EPS came in at -$0.63 falling short of the estimated -$0.10 by -530.00%.
Earnings released on 14 Nov 2024
EPS came in at -$0.65 falling short of the estimated -$0.38 by -71.05%.
Earnings released on 14 Aug 2024
EPS came in at -$0.66 falling short of the estimated -$0.58 by -13.79%.
Earnings released on 15 May 2024
EPS came in at -$0.73 surpassing the estimated -$0.79 by +7.59%.
Earnings released on 27 Mar 2024
EPS came in at -$0.63 surpassing the estimated -$0.78 by +19.23%, while revenue for the quarter reached $1.00 .
Earnings released on 14 Nov 2023
EPS came in at -$0.86 surpassing the estimated -$1.12 by +23.21%, while revenue for the quarter reached $79.57K .
Earnings released on 14 Aug 2023
EPS came in at -$1.11 falling short of the estimated -$0.92 by -20.65%, while revenue for the quarter reached $116.41K .
Stock split effective on 30 Jun 2023
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at -$1.02 falling short of the estimated -$0.14 by -628.57%, while revenue for the quarter reached $64.52K .
Earnings released on 30 Mar 2023
EPS came in at -$0.20 , while revenue for the quarter reached $123.44K .
Earnings released on 14 Nov 2022
EPS came in at -$1.08 falling short of the estimated -$0.18 by -500.00%, while revenue for the quarter reached $7.29K , missing expectations by -96.35%.
Earnings released on 12 Aug 2022
EPS came in at -$1.08 falling short of the estimated -$0.19 by -468.42%, while revenue for the quarter reached $6.55K , missing expectations by -97.82%.
Earnings released on 16 May 2022
EPS came in at -$1.08 falling short of the estimated -$0.17 by -535.29%, while revenue for the quarter reached $46.03K , missing expectations by -84.66%.
Earnings released on 31 Mar 2022
EPS came in at -$1.20 falling short of the estimated -$0.17 by -605.88%, while revenue for the quarter reached $1.94K , missing expectations by -99.35%.
Earnings released on 15 Nov 2021
EPS came in at -$1.08 falling short of the estimated -$0.14 by -671.43%, while revenue for the quarter reached $328.46K , beating expectations by +9.49%.
Earnings released on 16 Aug 2021
EPS came in at -$1.32 falling short of the estimated -$0.38 by -247.37%, while revenue for the quarter reached $1.36M , beating expectations by +354.35%.
Earnings released on 17 May 2021
EPS came in at -$1.56 , while revenue for the quarter reached $1.41M .
Earnings released on 31 Mar 2021
EPS came in at -$0.87 , while revenue for the quarter reached $698.47K .
Earnings released on 30 Sept 2020
EPS came in at -$0.49 , while revenue for the quarter reached $37.68K .
IKT Stock Performance
Access detailed IKT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.